Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment.

2025

Bolsewig K, Willemse EAJ, Sánchez-Juan P, Rábano A, Martínez M, Doecke JD, Bellomo G, Vermunt L, Alcolea D, Halbgebauer S, In ‘t Veld S, Mattsson-Carlgren N, Veverova K, Fowler CJ, Boonkamp L, Koel-Simmelink M, Hussainali Z, Ruiters DN, Gaetani L, Toja A, Fortea J, Pijnenburg Y, Lemstra AW, van der Flier WM, Hort J, Otto M, Hansson O, Parnetti L, Masters CL, Lleó A, Teunissen CE, Del Campo Milán M.
Nat Commun. 2025 Jan 29;16(1):1139. doi: 10.1038/s41467-025-56293-z. PMID: 39881147 Free PMC article.